Cerner (NASDAQ:CERN) had its price target trimmed by Cantor Fitzgerald from $83.00 to $80.00 in a research report report published on Wednesday. The brokerage currently has an overweight rating on the stock.

Several other research analysts have also issued reports on the company. Zacks Investment Research raised Cerner from a sell rating to a hold rating in a research report on Tuesday, December 26th. Stifel Nicolaus reaffirmed a hold rating on shares of Cerner in a research report on Wednesday, November 22nd. JPMorgan Chase & Co. lowered Cerner from an overweight rating to a neutral rating in a research report on Friday, October 27th. BidaskClub lowered Cerner from a buy rating to a hold rating in a research report on Friday, December 22nd. Finally, Piper Jaffray Companies reaffirmed a buy rating and set a $77.00 target price on shares of Cerner in a research report on Thursday, October 12th. One equities research analyst has rated the stock with a sell rating, twelve have assigned a hold rating and eight have assigned a buy rating to the company. The company has an average rating of Hold and an average price target of $67.05.

Cerner (NASDAQ CERN) opened at $61.31 on Wednesday. Cerner has a 1 year low of $51.26 and a 1 year high of $73.86. The stock has a market capitalization of $20,380.37, a PE ratio of 27.62, a P/E/G ratio of 1.80 and a beta of 0.90. The company has a debt-to-equity ratio of 0.11, a quick ratio of 2.75 and a current ratio of 3.01.

Cerner (NASDAQ:CERN) last announced its earnings results on Tuesday, February 6th. The company reported $0.58 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.61 by ($0.03). Cerner had a net margin of 16.86% and a return on equity of 16.82%. The business had revenue of $1.31 billion for the quarter, compared to analyst estimates of $1.33 billion. During the same period in the prior year, the company earned $0.61 earnings per share. The company’s quarterly revenue was up 4.5% on a year-over-year basis. equities analysts predict that Cerner will post 2.42 earnings per share for the current fiscal year.

In other news, CEO Clifford W. Illig sold 140,000 shares of the stock in a transaction dated Thursday, November 16th. The stock was sold at an average price of $65.52, for a total value of $9,172,800.00. Following the transaction, the chief executive officer now directly owns 1,229,719 shares of the company’s stock, valued at $80,571,188.88. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Chairman Clifford W. Illig sold 530,000 shares of the company’s stock in a transaction dated Monday, November 20th. The stock was sold at an average price of $65.54, for a total value of $34,736,200.00. Following the completion of the sale, the chairman now owns 1,229,719 shares in the company, valued at approximately $80,595,783.26. The disclosure for this sale can be found here. Insiders sold 784,000 shares of company stock worth $51,926,960 over the last three months. Corporate insiders own 13.11% of the company’s stock.

Institutional investors and hedge funds have recently modified their holdings of the company. Advisory Services Network LLC boosted its stake in shares of Cerner by 4.4% in the second quarter. Advisory Services Network LLC now owns 1,648 shares of the company’s stock worth $110,000 after buying an additional 70 shares during the last quarter. Fuller & Thaler Asset Management Inc. purchased a new stake in shares of Cerner in the third quarter worth about $121,000. Steward Partners Investment Advisory LLC purchased a new stake in shares of Cerner in the third quarter worth about $128,000. Cerebellum GP LLC purchased a new stake in shares of Cerner in the fourth quarter worth about $127,000. Finally, Fort Pitt Capital Group LLC purchased a new stake in shares of Cerner in the third quarter worth about $205,000. Hedge funds and other institutional investors own 81.99% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Cerner (CERN) PT Lowered to $80.00” was originally published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are viewing this news story on another domain, it was illegally copied and republished in violation of U.S. and international copyright & trademark laws. The legal version of this news story can be accessed at https://theolympiareport.com/2018/02/11/cerner-cern-pt-lowered-to-80-00.html.

About Cerner

Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.

Analyst Recommendations for Cerner (NASDAQ:CERN)

Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.